Anti-OBP2A/ LCN13/ OBP functional antibody
Anti-OBP2A/ LCN13/ OBP functional antibody for cell culture, ELISA & in-vivo assay
Go to OBP2A/OBP2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1145-Ab-1/ GM-Tg-hg-SE1145-Ab-2 | Anti-Human OBP2A monoclonal antibody | Human |
GM-Tg-rg-SE1145-Ab-1/ GM-Tg-rg-SE1145-Ab-2 | Anti-Rat OBP2A monoclonal antibody | Rat |
GM-Tg-mg-SE1145-Ab-1/ GM-Tg-mg-SE1145-Ab-2 | Anti-Mouse OBP2A monoclonal antibody | Mouse |
GM-Tg-cynog-SE1145-Ab-1/ GM-Tg-cynog-SE1145-Ab-2 | Anti-Cynomolgus/ Rhesus macaque OBP2A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1145-Ab-1/ GM-Tg-felg-SE1145-Ab-2 | Anti-Feline OBP2A monoclonal antibody | Feline |
GM-Tg-cang-SE1145-Ab-1/ GM-Tg-cang-SE1145-Ab-2 | Anti-Canine OBP2A monoclonal antibody | Canine |
GM-Tg-bovg-SE1145-Ab-1/ GM-Tg-bovg-SE1145-Ab-2 | Anti-Bovine OBP2A monoclonal antibody | Bovine |
GM-Tg-equg-SE1145-Ab-1/ GM-Tg-equg-SE1145-Ab-2 | Anti-Equine OBP2A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1145-Ab-1/ GM-Tg-hg-SE1145-Ab-2; GM-Tg-rg-SE1145-Ab-1/ GM-Tg-rg-SE1145-Ab-2; GM-Tg-mg-SE1145-Ab-1/ GM-Tg-mg-SE1145-Ab-2; GM-Tg-cynog-SE1145-Ab-1/ GM-Tg-cynog-SE1145-Ab-2; GM-Tg-felg-SE1145-Ab-1/ GM-Tg-felg-SE1145-Ab-2; GM-Tg-cang-SE1145-Ab-1/ GM-Tg-cang-SE1145-Ab-2; GM-Tg-bovg-SE1145-Ab-1/ GM-Tg-bovg-SE1145-Ab-2; GM-Tg-equg-SE1145-Ab-1/ GM-Tg-equg-SE1145-Ab-2 |
Products Name | Anti-OBP2A monoclonal antibody |
Format | mab |
Target Name | OBP2A |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-OBP2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1145-Ag-1 | Recombinant multi-species OBP2A/ LCN13/ OBP protein |
Target information
Target ID | GM-SE1145 |
Target Name | OBP2A |
Gene ID | 29991 |
Gene Symbol and Synonyms | hOBPIIa,LCN13,OBP,OBP2A,OBP2C,OBPIIa |
Uniprot Accession | Q9NY56 |
Uniprot Entry Name | OBP2A_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000122136 |
Target Classification | N/A |
The target: OBP2A, gene name: OBP2A, also named as LCN13, OBP, OBP2C, OBPIIa, hOBPIIa. This gene encodes a small extracellular protein belonging to the lipocalin superfamily. The protein is thought to transport small, hydrophobic, volatile molecules or odorants through the nasal mucus to olfactory receptors, and may also function as a scavenger of highly concentrated or toxic odors. The protein is expressed as a monomer in the nasal mucus, and can bind diverse types of odorants with a higher affinity for aldehydes and fatty acids. This gene and a highly similar family member are located in a cluster of lipocalin genes on chromosome 9. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.